Prophecy DeFi Announces Resignation of Director

Prophecy DeFi Announces Resignation of Director

Prophecy DeFi Inc. (CSE: PDFI) ("Prophecy DeFi" or the "Company"), announces the resignation of Stuart Hensman from the Board of Directors (the "Board").

"On behalf of the Company, I would like to thank Stuart for his contributions to the Board. We wish him all the best in his future endeavours," said John McMahon, CEO, Prophecy DeFi.

About Prophecy DeFi

Prophecy DeFi (CSE: PDFI) provides retail and institutional investors with access to the decentralized finance sector by bridging the gap between DeFi and traditional finance. Prophecy DeFi invests in diverse DeFi and Web 3.0 startups to create new business opportunities in a coherent ecosystem.

www.prophecydefi.com

For further information, please contact:

John McMahon, CEO
Tel: (416) 764-0314
Email: jmcmahon@prophecydefi.com

Forward-Looking Information

Certain information set forth in this news release may contain forward-looking information that involves substantial known and unknown risks and uncertainties. This forward-looking information is subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, the impact of general economic conditions, industry conditions, and dependence upon regulatory approvals and the possibility that the completion of the transaction may not occur. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking information. The parties undertake no obligation to update forward-looking information except as otherwise may be required by applicable securities law.

Neither the Canadian Securities Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR
FOR DISSEMINATION IN THE UNITED STATES.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/145972

News Provided by Newsfile via QuoteMedia

PDFI:CC
The Conversation (0)
Prophecy DeFi Announces New Appointment to Board of Directors

Prophecy DeFi Announces New Appointment to Board of Directors

Prophecy DeFi Inc. (CSE: PDFI) ("Prophecy DeFi" or the "Company") is pleased to announce that it has appointed Mr. Andy Dayes to the Company's Board of Directors, effective immediately.

Mr. Dayes has 30 years' experience in the financial services industry as an entrepreneur, a company principal, and a senior executive working with large financial institutions such as Wells Fargo and entrepreneurial firms such as Next Edge Capital and Efficient Capital in the institutional capital-raising space.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Prophecy DeFi Appoints New President and Head of Operations

Prophecy DeFi Appoints New President and Head of Operations

Prophecy DeFi Inc. (CSE: PDFI) ("Prophecy DeFi", "Prophecy", or the "Company"), a publicly traded investment firm focused on the decentralized finance (DeFi) sector, is pleased to announce the appointment of Paul Rekai as President & Head of Operations.

Paul will lead the next chapter of Prophecy's operations and growth. In this position, Paul will complement Prophecy's existing leadership team of experienced traditional finance and crypto operators and look to expand revenue streams by providing essential financial services for DeFi projects and investors alike.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Prophecy DeFi Announces Q1 2022 Financial Results

Prophecy DeFi Announces Q1 2022 Financial Results

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Prophecy DeFi Inc. (" Prophecy DeFi " or the " Company ") (CSE: PDFI), a publicly traded investment firm focused on the decentralized finance sector, is pleased to announce its financial results for the three months ended March 31, 2022 ("Q1").

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
PROPHECY DEFI'S INVESTMENT COMPANY LAYER2 BLOCKCHAIN CONTINUES TO IDENTIFY AND DEPLOY CAPITAL INTO HIGH YIELD DEFI OPPORTUNITIES

PROPHECY DEFI'S INVESTMENT COMPANY LAYER2 BLOCKCHAIN CONTINUES TO IDENTIFY AND DEPLOY CAPITAL INTO HIGH YIELD DEFI OPPORTUNITIES

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR
FOR DISSEMINATION IN THE UNITED STATES /

Prophecy DeFi Inc. (" Prophecy DeFi ", " Prophecy " or the " Company ") (CSE: PDFI) is pleased to provide investors with an operational update on its wholly owned subsidiary, Layer2 Blockchain Inc. (" Layer2 Blockchain ", " Layer2 ", or the " Company ").

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
PROPHECY DEFI ANNOUNCES GRANT OF OPTIONS

PROPHECY DEFI ANNOUNCES GRANT OF OPTIONS

/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR
FOR DISSEMINATION IN THE UNITED STATES /

 Prophecy DeFi Inc. (" Prophecy DeFi " or the " Company ") (CSE: PDFI) announces that it has granted an aggregate of 1,400,000 options to purchase common shares of the Company to an officer and consultants of the Company, exercisable at a price of $0.60 per common share for a period of three (3) years from the date of grant, in accordance with the terms of the Company's stock option plan. The common shares issuable upon exercise of the options are subject to a statutory hold period of four months and one day from the date of grant.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that a detailed biomarker analysis of the recently reported pre-clinical melanoma study conducted at Dalhousie University (the "Study") indicates that, beyond shrinking tumors on its own, Sona's Targeted Hyperthermia Therapy ("THT") also stimulates the innate immune system to target and eliminate untreated (contralateral) tumors when combined with a standard immunotherapeutic drug, IL-2. (See figure #1, below.) On the basis of efficacy data achieved in two different murine cancer models (triple negative breast cancer and malignant melanoma), the Company is now proceeding with safety and biocompatibility testing that will be required by regulating agencies to enter into human studies.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
E-Power Resources Inc. Announces Commencement of the 2024 Tetepisca Exploration Program

E-Power Resources Inc. Announces Commencement of the 2024 Tetepisca Exploration Program

Commencement of the Tetepisca Exploration Program for 2024

E-Power Resources Inc. (CSE: EPR) ("E-Power" or the "Company") announces that it has mobilized its exploration crew to the Tetepisca Graphite Project and the 2024 exploration program is underway.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
PRINCIPAL TECHNOLOGIES ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT

PRINCIPAL TECHNOLOGIES ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT

Principal Technologies Inc. (the " Company ") (TSXV: PTEC) (FSE: J07), is pleased to announce the closing of the first tranche (" Tranche 1 ") of its previously announced non-brokered private placement (the " Offering ") with one investor, MRPT Invest UG (" MRPT "), a company owned and controlled by Markus Mair . The Company issued a total of 4,000,000 units at $0.25 per unit for gross proceeds of $1,000,000 . Each unit (a " Unit ") will consist of one common share (a ' Share ") of the Company and one common share purchase warrant (a " Warrant "). Each Warrant entitles the holder to purchase one additional Share of the Company at $0.30 for a period of two (2) years from the date of closing. The Warrants are subject to a blocker term that prohibits exercise of the Warrants to the extent the holder would as a result of any exercise exceed 19.99% of then issued Shares.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer

Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that its targeted hyperthermia therapy ("THT") demonstrated positive results in a second preclinical cancer model. Findings just presented at the 2024 STING & TLR Targeted Therapies Summit for immunotherapies in San Diego, California, show that Sona's THT achieved responses in a preclinical melanoma model equal to that which was recently reported from its triple negative breast cancer study. THT effectively treated melanoma tumors in all animals when administered on its own. Further, when THT was combined with doses of interleukin-2 ("IL-2"), a standard immunotherapy, a synergistic effect was shown whereby greater treatment response, measured by tumor volume reduction, was achieved in comparison to either approach alone.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Apple The Exchange TRX to welcome its first customers this Saturday, June 22, in Kuala Lumpur

Apple The Exchange TRX to welcome its first customers this Saturday, June 22, in Kuala Lumpur

Apple's first retail location in Malaysia will offer its full lineup of products and services, unparalleled support from over 160 team members, and sessions with local creatives

Apple® today previewed Apple The Exchange TRX, the first Apple Store® in Malaysia. Located in the heart of Kuala Lumpur's new Tun Razak Exchange (TRX) central business district, the new store will deliver the magic of Apple in the country like never before. Customers can discover and buy Apple's innovative lineup of products and services, receive exceptional service from knowledgeable team members, and learn how to get the most out of their devices through free Today at Apple® sessions.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
XReality Group

Additional Working Capital Secured

xReality Group Limited (“XRG” or the “Company”) is pleased to announce that it has secured an additional $500,000 in working capital through its senior debt holder, Causeway Financial. The additional working capital will be utilised to provide inventory for the increasing demand in the United States markets.

Keep reading...Show less

Latest Press Releases

Related News

×